NCT02087735已完成1 期
Measurement of Urinary Catabolites of the Proanthocyanidines (PACs) in Healthy Young Women as Biomarkers of Consumption of Cranberry Extracts.
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 15
- 试验地点
- 1
- 主要终点
- Urinary catabolites of PACs
研究概览
简要总结
The purpose of this cross over pilot study is to investigate the urinary catabolites of Proanthocyanidines (PACs) as biomarkers of cranberry extracts in healthy young women.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Healthy women.
- •18 to 40 years.
排除标准
- •No internet access.
- •No refrigerator access during the 9 hours of sample collection.
- •Women who had or expect to take antibiotic.
- •Women who had or expect to take cranberries, blueberries or bilberries in the form of berries, juice or extracts.
- •Women who had or expect to take dark chocolate.
- •Women who had personal history of acute or chronic renal failure.
研究组 & 干预措施
cranberry extract 3.
Placebo Comparator
Two capsules with a proanthocyanidin standardized cranberry extract of 2 mg.
干预措施: Cranberry extract (Dietary Supplement)
cranberry extract 2.
Experimental
Two capsules with a proanthocyanidin standardized cranberry extract of 36 mg.
干预措施: Cranberry extract (Dietary Supplement)
cranberry extract 1
Experimental
One capsule with a proanthocyanidin standardized cranberry extract of 36 mg and one capsule of placebo cranberry extract.
干预措施: Cranberry extract (Dietary Supplement)
结局指标
主要结局
Urinary catabolites of PACs
时间窗: within 9 hours following the intake of cranberry extracts
次要结局
未报告次要终点
研究者
Sylvie Dodin
Sylvie Dodin, MD
Laval University
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Urine Metabolites in the Diagnosis of DiseaseCrohn DiseaseSmall Intestinal Bacterial Overgrowth Syndrome (SIBO)Colorectal CancerCeliac DiseaseNCT06710067Luventix, Inc.1,250
招募中
不适用
Urine and Stool Analysis in Kidney Stone DiseaseUrolithiasisNCT01637506University of British Columbia20
已完成
1 期
Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male ParticipantsHealthy VolunteersNCT06045000DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company8
已完成
1 期
Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer PatientsAdvanced Solid TumorsNCT02622932Chia Tai Tianqing Pharmaceutical Group Co., Ltd.6
已完成
不适用
Metabolism and Absorption of Anthocyanins From Extract and Whole Blueberry Powder Confections in Healthy AdultsHealthy DietNutrition Aspect of CancerNCT04329962Ohio State University Comprehensive Cancer Center12